For more than 50 years, Speichim Processing (a subsidiary of the Séché Environnement Group) has been developing innovative techniques to offer to industry players (chemicals, petrochemicals, pharmaceuticals) the opportunity to recover their hazardous wastes and chemical products.
Our areas of expertise are focused around 3 major poles :
– The regeneration of industrial solvents ;
– The purification of synthesis intermediates ;
– The trading of solvents.
In this coronavirus crisis and as a full member of SICOS (union for the synthetic organic chemical industry and biochemistry) Speichim Processing is committed to meeting the needs of an efficient, reactive and competitive industrial manufacturing in Europe.
Since the beginning of this unprecedented health crisis, the 10,000 employees (members of SICOS) have been fully mobilized on our territory to ensure the production of active ingredients and pharmaceutical intermediates that are absolutely essential to guarantee a secure supply of medicines to our hospitals and pharmacies.
In this complex and global drug production chain, our companies, players in pharmaceutical synthesis, represent one of the essential links to guarantee the long-term health safety of our country.
Our companies have withstood the wave of massive relocation of a large part of this value chain that has gradually led the European pharmaceutical industry to depend on Asia (India and China).
And they have thus acquired unrivalled know-how enabling them to provide rapid and concrete responses to tomorrow’s challenges.
In order to continue to ensure the production of active ingredients, pharmaceutical intermediates and regulated raw materials on our territory, we have constantly invested in the best technologies available and improved the flexibility and productivity of our facilities to meet an ever more challengin demand and a competition that is not always subject to the same regulatory constraints (quality, safety, environment).
A national pharmaceutical synthesis (coordinated at the European level ) plan must be implemented as soon as possible and be based on :
– Securing the production of active ingredients and strategic intermediates ;
– Supporting the investment in new processes and innovative means of production. This will improve the economic and environmental performance of our facilities ;
– Implementing a revised European regulation that integrates the requirement for continuity of supply and sustainability for manufacturers ;
– Training and developing skills for employees in this business sector.
We are working to rebuild a European pharmaceutical synthesis industry and to promote the most critical chains from an innovative, exemplary, quality and competitive point of view.
We – Speichim Processing as well as the members of SICOS – responsible and committed actors, are ready to take up the challenge.
List of signatories :
Vincent TOURAILLE I President I SICOS Biochemistry
Jacques BROM I CEO I SANOFI CHEMIE
Laurent CARMONA I Director of Industrial Operations I SPEICHIM PROCESSING
Pierre CHARRIER I CEO I DIVERCHIM
Bernard FRAISSE I President & CEO I FAREVA
Frédéric GAUCHET I CEO I MINAKEM
Pierre GIULIANO I Managing Director I LA MESTA CHIMIE FINE
Philippe GUERRET I CEO I M2i Life Sciences
Alexandre GRUMAN I Managing Director I PMC Isochem
Marie-Anne GUILLOT I President I INTEROR SAS
Pierre LUZEAU I CEO I SEQENS
Jean MAZERES I Managing Director – Strategy & Sourcing I UNIPEX SOLUTIONS France S.A.S.
David SIMONNET I President – Managing Director I AXYNTIS Group
Dr. Michel SPAGNOL I Chairman & CEO I NOVASEP
Pierre VENESQUE I CEO I ORIL (SERVIER Group)
Gilles ZUBERBUHLER I Chairman I WEYLCHEM LAMOTTE